Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer’s disease

BACKGROUND: Familial Alzheimer’s disease (FAD) is caused by mutations in the amyloid precursor protein (APP) or presenilin (PS). Most PS mutations, which account for the majority of FAD cases, lead to an increased ratio of longer to shorter forms of the amyloid beta (Aβ) peptide. The therapeutic rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Blain, Jean-François, Bursavich, Matthew G., Freeman, Emily A., Hrdlicka, Lori A., Hodgdon, Hilliary E., Chen, Ting, Costa, Don E., Harrison, Bryce A., Kapadnis, Sudarshan, Murphy, Deirdre A., Nolan, Scott, Tu, Zhiming, Tang, Cuyue, Burnett, Duane A., Patzke, Holger, Koenig, Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004293/
https://www.ncbi.nlm.nih.gov/pubmed/27572246
http://dx.doi.org/10.1186/s13195-016-0199-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004293/
https://www.ncbi.nlm.nih.gov/pubmed/27572246
http://dx.doi.org/10.1186/s13195-016-0199-5

Ejemplares similares